Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $114,518,000 | $112,459,000 | $122,154,000 | $129,290,000 |
| Short-Term Investments | $14,598,000 | $12,862,000 | $14,714,000 | $13,141,000 |
| Receivables | $47,223,000 | $42,983,000 | $39,753,000 | $38,112,000 |
| Inventory | $22,391,000 | $21,176,000 | $18,922,000 | $16,412,000 |
| Other Curr. Assets | $5,058,000 | $4,542,000 | $3,631,000 | $3,221,000 |
| Total Curr. Assets | $203,788,000 | $194,022,000 | $199,174,000 | $200,176,000 |
| Property Plant & Equip (Net) | $59,899,000 | $49,462,000 | $43,209,000 | $39,069,000 |
| Goodwill | $1,294,000 | $1,444,000 | $0 | $0 |
| Intangibles | $4,679,000 | $5,387,000 | $945,000 | $1,324,000 |
| Long-Term Investments | $71,494,000 | $76,813,000 | $46,131,000 | $39,378,000 |
| Tax Assets | $1,911,000 | $0 | $1,342,000 | $1,153,000 |
| Other NC Assets | -$2,000 | $1,646,000 | $23,113,000 | $21,753,000 |
| Total NC Assets | $139,275,000 | $134,752,000 | $114,740,000 | $102,677,000 |
| Other Assets | $5,000 | $5,000 | $3,000 | $5,000 |
| Total Assets | $343,068,000 | $328,779,000 | $313,917,000 | $302,858,000 |
| Liabilities | – | – | – | – |
| Payables | $9,910,000 | $9,612,000 | $14,918,000 | $13,225,000 |
| Short-Term Debt | $1,065,000 | $1,071,000 | $1,071,000 | $1,071,000 |
| Tax Payable | $3,627,000 | $1,889,000 | $2,338,000 | $2,938,000 |
| Deferred Revenue | $0 | $4,539,000 | $15,847,000 | $11,121,000 |
| Other Curr. Liab. | $24,063,000 | $21,884,000 | $9,075,000 | $5,079,000 |
| Total Curr. Liab. | $47,226,000 | $45,938,000 | $42,578,000 | $32,160,000 |
| LT Debt | $1,694,000 | $76,000 | $147,000 | $219,000 |
| Deferred Rev, NC | $0 | $603,000 | $8,408,000 | $8,216,000 |
| Deferred Tax Liab, NC | $4,304,000 | $4,518,000 | $1,813,000 | $4,170,000 |
| Other NC Liab. | $9,753,000 | $10,559,000 | $1,817,000 | $2,342,000 |
| Total NC Liab. | $16,439,000 | $15,765,000 | $12,935,000 | $15,816,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1,097,000 | $953,000 | $1,077,000 | $1,170,000 |
| Total Liabilities | $63,665,000 | $61,703,000 | $55,513,000 | $47,976,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8,473,000 | $8,473,000 | $8,473,000 | $8,473,000 |
| Retained Earnings | $257,881,000 | $242,578,000 | $235,569,000 | $236,192,000 |
| AOCI | $0 | $48,455,000 | $37,155,000 | $25,671,000 |
| Other Equity | $55,657,000 | $0 | $0 | $0 |
| Total Equity | $276,822,000 | $264,871,000 | $256,362,000 | $253,165,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $2,581,000 | $2,205,000 | $2,042,000 | $1,717,000 |
| Total Liab. & Tot. Equity | $343,068,000 | $328,779,000 | $313,917,000 | $302,858,000 |
| Net Debt | -$111,759,000 | -$111,312,000 | -$120,936,000 | -$128,000,000 |